News

GCRF 2023 Walk For A Cure-New York

Thank you to all those who attended the 2023 GCRF New York Walk For A Cure. We are so grateful that you all came out to support GCRF and fight for a cure! Even though it was raining and not many of you walked, it was good to see so many of our friends and supporters. The amazing GIST Cancer Doctors and researchers attended including our dedicated spokesman, NBA great, Walt Frazier. We would like to take this opportunity to thank everyone for coming out and supporting the fight against GIST Cancer. Please spread the word that this fight will not end until a cure is found. Keep hope alive and donate now! Remember 100% of all donations received goes directly to GIST Cancer Research.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

Thank You GCRF
for the Continued Support of
Over $1.3 Million Dollars
to the
OHSU Knight Cancer Institute

The OHSU Knight Cancer Institute
Presented a Thank You Award to
Tania and Robert Stuntman and GCRF by
Michael Heinrich, M.D. & Christopher Corless, M.D., Ph.D.
at the Conference
Highlighting Advancements in
Gastrointestinal Stromal Tumors (GIST) Research
on May 9, 2017.
The GIST Cancer Research Fund has Donated
Over $1,300,000
to the Heinrich-Corless Labs in their research
to find a cure for GIST Cancer.

2023 GIST Cancer Education Conference & Lunch • Portland, Oregon

PLEASE JOIN US
2023 GIST EDUCATION CONFERENCE AND LUNCHEON

The OHSU Knight Cancer Institute and the GIST Cancer Research Fund cordially invite you to Oregon Health & Science University for a one-day education conference highlighting advancements in Gastrointestinal Stromal Tumors (GIST) Research.

Thursday, October 12, 2023
9 a.m. to 2 p.m.

Featuring
Michael Heinrich, M.D.
Christopher Corless, M.D., Ph.D.

Robertson Life Sciences Building
Lecture Hall 3A003B
2730 SW Moody Avenue, Portland, Oregon 97201

The labs of Dr. Michael Heinrich, Dr. Christopher Corliss and Dr. Brian Druker are relentless in their dedication to advancing treatment options for patients with gastrointestinal stromal tumors (GIST) and other cancers.

This event is always an excellent opportunity to connect and share information with patients, families, and friends who feel passionate about finding novel GIST treatments. Plus, we love the chance to see familiar faces and meet new people who care about GIST. Of course, we want to express our deep appreciation to the GCRF community for their incredibly generous donation. With your amazing fundraising efforts, we are able to continue to work hard to find a cure for this devastating disease.

Long-Term Survival Rates For GIST Patients


The SWOG study shows strong long-term survival rates for patients with GIST. "This is a really exciting finding," said Dr. Michael Heinrich, a SWOG investigator and a professor of medicine and cell and developmental biology at Oregon Health & Science University, where SWOG is based. SWOG is a global cancer research community of over 12,000 members in 47 states and six foreign countries who design and conduct publicly funded clinical trials. Published in JAMA Oncology.

A Message of Thanks: Jonathan A. Fletcher, MD • Brigham and Women’s Hospital

An update and message of thanks for the GIST Cancer Research Fund from Jonathan A. Fletcher, MD, and his team at Brigham and Women’s Hospital: (in order of appearance) Nacef Bahri, Alexandra Lauria, Meijun Zhu, MD, Bin Li, MD, PhD, Stacy Yanofsky, Armelle Dufresne, MD, PhD, Wenbin Ou, PhD, and Anastasios (Tasos) Kyriazoglou, MD, PhD.

Fox Chase Cancer Center & GCRF

This video highlights advances in research and treatment for Gastrointestinal Stromal Tumors made at Fox Chase Cancer Center in Philadelphia. Fox Chase is grateful to the GIST Cancer Research Fund and its founders, Tania and Robert Stutman, for their generous support. In the video, Martin Belinkey, PhD, Staff Scientist, Lori Rink, PhD, Assistant Professor and Margaret von Mehren, MD, Dept. of Hematology/Oncology share some of the advances made over the past year, as well as what they will pursue in the coming year with this financial support.

The research studies by Martin Belinkey and Lori Rink can be found in the links below:

Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case

Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic effects in Preclinical Study of Gastrointestinal Stromal Tumor

Memorial Sloan Kettering Cancer Center - GIST Cancer Research Fund

March 30, 2016

GIST Education Conference & Lunch • Portland, Oregon

OSHU_group

The 2016 GCRF Conference and Luncheon at Oregon Health and Science University’s Knight Cancer Institute was held on May 10, 2016. The labs of Dr. Michael Heinrich, Dr. Christopher Corliss and Dr. Brian Druker are relentless in their dedication to advancing treatment options for patients with gastrointestinal stromal tumors (GIST) and other cancers. The teams are actively working on a variety of projects that are yielding promising results:
The search for a master key
Strategies to decrease KIT production
Identifying new types of GIST
Establishing model systems for SDH-deficient GIST to test new strategies

Dr. Michael Heinrich gave a presentation which include a review of the the projects he and his team of researchers are currently working on at OHSU.

We would like to extend our sincere gratitude to everyone who participated in the 2016 Annual GCRF Conference and Luncheon. It was wonderful to see so many of you and we hope you found a sense of community, patient support and helpful information at this event. Additionally, we want to thank the GCRF for their incredibly generous donation. With your amazing fundraising efforts, we are able to continue to work hard to find a cure for this devastating disease.

OSHU_group

Please click on the following link to view the presentations from the Conference: